Expression of Hepatocyte Growth Factor Activator Inhibitor Type 1 in Human Hepatocellular Carcinoma and Postoperative Outcomes

被引：0
|
作者：
Mayumi Funagayama
Kazuhiro Kondo
Kazuo Chijiiwa
Hiroaki Kataoka
机构：
[1] Miyazaki University School of Medicine,Department of Surgical Oncology and Regulation of Organ Function
[2] University of Miyazaki,Section of Oncology and Regenerative Biology, Department of Pathology, Faculty of Medicine
来源：
World Journal of Surgery | 2010年 / 34卷
关键词：
Overall Survival; Tace; Hepatocyte Growth Factor; Overall Survival Rate; Tumor Multiplicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1563 / 1571
页数：8
相关论文
共 50 条
  • [1] Expression of Hepatocyte Growth Factor Activator Inhibitor Type 1 in Human Hepatocellular Carcinoma and Postoperative Outcomes
    Funagayama, Mayumi
    Kondo, Kazuhiro
    Chijiiwa, Kazuo
    Kataoka, Hiroaki
    WORLD JOURNAL OF SURGERY, 2010, 34 (07) : 1563 - 1571
  • [2] Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma
    Nagata, K
    Hirono, S
    Ido, A
    Kataoka, H
    Moriuchi, A
    Shimomura, T
    Hori, T
    Hayashi, K
    Koono, M
    Kitamura, N
    Tsubouchi, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 289 (01) : 205 - 211
  • [3] Expression of hepatocyte growth factor in human hepatocellular carcinoma
    Guirouilh, J
    Le Bail, B
    Boussarie, L
    Balabaud, C
    Bioulac-Sage, P
    Desmoulière, A
    Schuppan, D
    Rosenbaum, J
    JOURNAL OF HEPATOLOGY, 2001, 34 (01) : 78 - 83
  • [4] Expression of hepatocyte growth factor activator inhibitor type 1 in endothelial cells.
    Akiyama Y.
    Nagai M.
    Komaki W.
    Marutsuka K.
    Asada Y.
    Kataoka H.
    Human Cell, 2006, 19 (3) : 91 - 97
  • [5] Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta
    Kataoka, H
    Meng, JY
    Itoh, H
    Hamasuna, R
    Shimomura, T
    Suganuma, T
    Koono, M
    HISTOCHEMISTRY AND CELL BIOLOGY, 2000, 114 (06) : 469 - 475
  • [6] Localization of hepatocyte growth factor activator inhibitor type 1 in langhans' cells of human placenta
    Kataoka H.
    Meng J.-Y.
    Itoh H.
    Hamasuna R.
    Shimomura T.
    Suganuma T.
    Koono M.
    Histochemistry and Cell Biology, 2000, 114 (6) : 469 - 475
  • [7] In vivo expression of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in preeclamptic term human placenta
    Ishikawa, G
    Mori, M
    Isozaki, T
    Kataoka, H
    Takeshita, T
    Takizawa, T
    PLACENTA, 2005, 26 (8-9) : A53 - A53
  • [8] Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma
    Betsunoh, Hironori
    Mukai, Shoichiro
    Akiyama, Yutaka
    Fukushima, Tsuyoshi
    Minamiguchi, Naoki
    Hasui, Yoshihiro
    Osada, Yukio
    Kataoka, Hiroaki
    CANCER SCIENCE, 2007, 98 (04) : 491 - 498
  • [9] Expression of Hepatocyte Growth Factor Activator Inhibitor Type-1 (HAI-1) in Prostate Cancer
    Yasuda, Kenji
    Komiya, Akira
    Watanabe, Akihiko
    Morii, Akihiro
    Oya, Takeshi
    Nagakawa, Osamu
    Fujiuchi, Yasuyoshi
    Fuse, Hideki
    ANTICANCER RESEARCH, 2013, 33 (02) : 575 - 581
  • [10] Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Suppressor of Intestinal Tumorigenesis
    Hoshiko, Shinri
    Kawaguchi, Makiko
    Fukushima, Tsuyoshi
    Haruyama, Yukihiro
    Yorita, Kenji
    Tanaka, Hiroyuki
    Seiki, Motoharu
    Inatsu, Haruhiko
    Kitamura, Kazuo
    Kataoka, Hiroaki
    CANCER RESEARCH, 2013, 73 (08) : 2659 - 2670
12345